ECM
VRTX icon

Evergreen Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Evergreen Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
4,222
-885
-17% -$392K 0.04% 334
2026
Q1 		$2.28M Buy
5,107
+306
+6% +$143K 0.05% 296
2025
Q4 		$2.18M Buy
4,801
+2,304
+92% +$993K 0.05% 293
2025
Q3 		$978K Sell
2,497
-152
-6% -$63.5K 0.02% 412
2025
Q2 		$1.18M Sell
2,649
-149
-5% -$68.7K 0.04% 334
2025
Q1 		$1.36M Buy
2,798
+259
+10% +$121K 0.05% 292
2024
Q4 		$1.02M Sell
2,539
-101
-4% -$46.8K 0.03% 332
2024
Q3 		$1.23M Buy
2,640
+4
+0.2% +$1.92K 0.04% 307
2024
Q2 		$1.24M Buy
2,636
+220
+9% +$95.5K 0.04% 284
2024
Q1 		$1.01M Buy
2,416
+12
+0.5% +$5.07K 0.04% 292
2023
Q4 		$978K Sell
2,404
-52
-2% -$19.2K 0.04% 297
2023
Q3 		$854K Sell
2,456
-11
-0.4% -$3.85K 0.04% 304
2023
Q2 		$868K Buy
2,467
+939
+61% +$316K 0.04% 306
2023
Q1 		$481K Buy
1,528
+60
+4% +$18K 0.02% 383
2022
Q4 		$424K Buy
1,468
+18
+1% +$5.49K 0.02% 400
2022
Q3 		$420K Buy
1,450
+448
+45% +$129K 0.02% 372
2022
Q2 		$283K Sell
1,002
-167
-14% -$44.7K 0.01% 436
2022
Q1 		$305K Buy
1,169
+231
+25% +$54.8K 0.01% 478
2021
Q4 		$206K Buy
+938
New +$182K 0.01% 591
2020
Q3 		– Sell
-741
Closed -$215K – 441
2020
Q2 		$215K Buy
+741
New +$201K 0.02% 351

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Evergreen Capital Management's VRTX Position: Q2 2026 in Review

Evergreen Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, selling an estimated $392K and leaving 4,222 shares worth $2.1M. The position accounts for 0.04% of the portfolio, ranked #334.

Evergreen Capital Management first reported a position in VRTX in Q2 2020 and has held it in 20 quarters since. The position peaked at $2.28M in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Evergreen Capital Management held 4,222 shares of Vertex Pharmaceuticals worth $2.1M as of Q2 2026.
  • Evergreen Capital Management sold 885 Vertex Pharmaceuticals shares in Q2 2026, an estimated $392K.
  • Vertex Pharmaceuticals made up 0.04% of Evergreen Capital Management's portfolio in Q2 2026, its #334 holding.
  • Evergreen Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • Evergreen Capital Management's Vertex Pharmaceuticals position peaked at $2.28M in Q1 2026.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.